Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for Paliperidone depot formulations

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 03, 2027 · 371 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Paliperidon, in 3-Monats-Depot-Darreichungsformen, ATC N05AX13

52/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

52 / 100

Złożoność

48 / 100

Czynniki ryzyka

Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...

To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Non-exclusive rebate agreement for pharmaceutical products: Paliperidone in 3-month depot dosage forms (ATC N05AX13).
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Pokaż pełne podsumowanie

This is an open-house supply arrangement by AOK Bayern for Paliperidone in 3-month depot formulations (ATC N05AX13). It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 01.11.2025 to 31.10.2027, with contract entry possible at any time until 03.09.2027. Submission is electronic via DTVP with a qualified electronic signature or by signed paper originals in duplicate; German language is required, and non-German documents must include a German translation.

Ryzyka

Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...

To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for Paliperidone depot formulations

Supply arrangement for Paliperidone in 3-month depot dosage forms (ATC N05AX13). The lot is an open-house rebate agreement, not a selective tender. Contract terms are pre-set and non-negotiable. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Oct 2025 - Oct 2027

Kategoria

Pharmaceutical products

Termin

Deadline Sep 03, 2027

Szczegóły zamówienia

Data publikacji
14 Sep 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
602050-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30